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and Clinical Relevance 

...whatever be our activity, facts go quicker than we, and we cannot 
catch them; while the scientist discovers one fact, there happen 
milliards of milliards in a cubic millimeter of his body. 
H, Poincare 
The palm at the end of the mind, 
Beyond the last thought, rises 
In the bronze decor, 
A gold-feathered bird 
Sings in the palm, without human meaning 
Without human feeling, a foreign song. 
You know then that it is not the reason 
That makes us happy or unhappy. 
The bird sings. Its feathers shine. 
The palm stands on the edge of space. 
The wind moves slowly in the branches. 
The bird's fire-fangled feathers dangle down. 
"Of Mere Being", W. Stevens 
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Int roduction 
In recent years much evidence has accumulated to suggest 
that a pathophysiologic functioning of CNS dopaminergic 
neural systems may play an etiologic role in schizophrenia 
( Randrup and Munkvad, 1971; Klawans et al., 1972; Snyder, 1972 
Stevens, 1973 ). This hypothesis has arisen in part from a 
fascinating reciprocity of certain neurologic and psychiatric 
disorders. 
1. Parkinson's disease which presents clinically with the 
triad of resting tremor, rigidity and bradykinesia, is character¬ 
ized pathologically most consistently by degeneration of the 
melanin containing nuclei of the brainstem, esp. the substantia 
nigra ( Blackwood et al., 1963 ). The substantia nigra has been 
shown by histof1ourescent techniques to contain dopaminergic cell 
bodies whose axons project rostrally to the ipsilateral striatum 
( Anden et al., 1969; Ungerstedt, 1971 )• The hypothesis that 
an alteration of dopamine metabolism due to the nigral degeneration 
is important in the pathogenesis of Parkinson's disease ( Hornykiewicz, 
1966 ) led to the attempt to treat this disorder by administering 
to patients the dopamine precursor L-Dopa ( Cotzias et al., 1967 ). 
The success of this pharmacotherapy has led to large numbers of 
Parkinsonian patients on chronic large doses of L-Dopa. This 
population has been found to manifest a high percentage of psychiatric 
disorders, including fullblown psychosis directly attributable 
to the L-Dopa therapy ( Celesia and Barr, 1970 ). Furthermore, 

the development of psychosis in these patients is often as¬ 
sociated with the concurrent development of dyskinetic movements, 
the most common of which is a bucco-1ingua1 dyskinesia. Both the 
psychosis and the dyskinesia resolve with lowering of the 
L-Dopa dose. 
2. Huntington's chorea, a dominantly inherited disorder 
characterized by dyskinesia, hyperkinesia, hypotonia and 
dementia is most often found to show on pathologic investigation 
a degeneration of caudate nucleus, putamen, and frontal cortex 
( Blackwood et al., 1963 ). This disease has been noted to be 
associated with psychosis since the time it was first described 
( Huntington, 1872 ). Hallucinations and paranoid behavior are 
common in patients with this disease (Bolt, 1970 ) and schizo- 
phrenia has been considered the most common concommitant disorder 
( Brothers, 1964 ). While organic dementia ultimately develops, 
the earliest presentation of this disease may be a psychiatric 
disorder not infrequently misdiagnosed as schizophrenia. It has 
been suggested that the motor disturbance results from an in¬ 
creased sensitivity of dopamine receptors in the striatum 
( Klawans et al., 1972 ). This hypothesis has led to the success¬ 
ful use of L-Dopa as a provocative test for young individuals 
genetically at risk ( Klawans et al., 1972b ). The motor dis¬ 
turbance has been shown to respond to treatment with neuroleptic, 
dopamine blocking agents ( Fog and Pakkenberg, 1970 ). It has 
recently been reported that the GABA is reduced in the basal 
ganglia of patients with Huntington's chorea ( Perry, et al., 1973 ). 

Though the significance of this finding is uncertain, there is 
evidence that GABA may play a role as an inhibitory neuro¬ 
transmitter. it is further worth noting that psychiatric 
disorders are very commonly associated with other choreatic 
disorders as well ( Freeman et al., 1965 ). 
3. Antipsychotic drugs of the phenothiazine class and 
the butyrophenone haloperidol increase dopamine turnover in the 
striatum ( Nyback and Sedvall, 1968; O'Keefe et al., 1970 ), 
apparently as a result of dopamine receptor blockade and a 
compensatory neuronal feedback ( Carlsson and Lindquist, 1963; 
Bunney et al., 1973 ). Since their therapeutic introduction by 
Delay and Deniker (1952) these drugs have led to a revolution 
in the management of psychosis. The widespread use of these 
agents has however also been responsible for the appearance of 
several new neurologic disorders. A drug induced Parkinsonism 
is relatively common among patients on chronic antipsychotic 
medications. It should be noted that attempts to treat this 
drug-induced Parkinsonism by the administration of L-Dopa had 
to be curtailed due to the exacerbation of the psychosis 
( Yaryura-Tobias, 1970 ). 
Another group of disorders linked to chronic antipsychotic 
use is the tardive dyskinesias (Crane, 1968; American College of 
Neuropsychopharmacology, 1973 ), which often present with a bucco- 
lingual dyskinesia. This disorder frequently becomes manifest 
after lowering or discontinuing antipsychotic medications 
( though it does occur without alterations of dosage ) after 

prolonged periods of use. It has been suggested that the tardive 
dyskinesias result from a hypersensitivity of dopamine receptors 
caused by a chemical denervation by prolonged exposure to 
blocking agents ( Klawans et al., 197? )< 
ft. Amphetam ? ne has been shown to be capable in high 
doses of producing in humans a psychosis often indistinguish¬ 
able from an acute paranoid schizophrenia. Snyder ( 1972 ) 
has recently offered a review of the pertinent literature. 
Amphetamine has been shown to have several actions on central 
monoamines, the most important of which appears to be the release 
of newly synthesized catecholamines from presynaptic nerve 
endings ( Anden, 1970; Carlsson, 1970; Fuxe and Ungerstedt, 
1970 ). It is of note that the psychosis induced by amphetamine 
is often accompanied by stereotyped activities and responds well 
to treatment with antipsychotic phenothiazines. 
The data presented above indicates that drugs which in¬ 
crease functionally active dopamine (DA) in the CNS ( such as 
L-Dopa and amphetamine ), while useful in the treatment of 
hypokinetic, rigid states ( Parkinson's disease ), tend to pro¬ 
duce as side effects hyperkinesia, dyskinesia, hypotonia and 
psychosis. On the other hand, those drugs which decrease 
functionally active DA ( phenothiazines and haloperidol ) are 
useful in the treatment of hyperkinetic, dyskinetic and psychotic 
states, but tend to produce Parkinsonian side effects. This 
apparant wedding of psychic and motor responses to changes 
in central dopaminergic activity has led Klawans ( Klawans et al., 

1972 ) to suggest a role for striatal dopamine in the patho¬ 
genesis of schizophrenia. 
It is known however from histof1ourescent microscopic 
investigations that there are 3 dopaminergic pathways in the 
CNS ( Ungerstedt, 1971 ). (See figures 1 & 2) 1) With cell 
bodies in the substantia nigra zona compacta ( cell group A9, 
as named by Dahlstrom and Fuxe (1965) ) projects to ipsilateral 
caudate and putamen - the nigrostriata1, NS, pathway; 2) With 
cell bodies lying just dorsal to the nuc, interpeduncu1 aris 
( A10 ) projects rostrally to distribute terminals to the 
olfactory tubercle (OT), nuc. accumbens, nuc. interstitia 1 i s 
stria terminal is ( dorsalis ), and the nuc. amygda1oideus 
centralis. This projection has been termed the meso-limbic, 
ML, pathway; 3) Cell bodies are located within the nuc. 
arcuatus ( A12 ) and project to innervate the median emminence- 
the tuberoinfundibu1 ar system. ( Two more groups of DA containi 
cells have been described but their projections have not as yet 
been determined. The A8 group lies just caudal to the sub¬ 
stantia nigra and probably projects to striatum. The A13 
group lies dorsolateral to the nuc. do rsorned i a 1 i s hypothal¬ 
ami and may give rise to a rostral projection joining the 
medial forebrain bundle , MFB. 
The first of the DA projections has been convincingly 
invoked in the pathophysiology of Parkinson's disease. The 
third, tube ro-i nf und i bu 1 a r system, has been implicated i r, the 
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Anatomy of CMS DA Pathways in the Rat 
( after Ungerstedt, 1970) 








regulation of gonadotropin secretion from the anterior pituitary 
( Fuxe and Hokfelt, 19&9; Kamberi et al., 1970 ). The meso- 
limbic pathway remains obscure however with regard to its 
function. 
Wilson ( 1972 ) has suggested that the olfactory tubercle, 
0T, and nuc. accumbens, NAc, form a unitary structure, traversed 
by the MFB, that may be thought of as a "ventral striatum". 
The 0T and NAc receive afferents from the hippocampus, 
piriform cortex, and ventral tegmentum (A10 ) and send efferents 
to the substantia innominata and DM nuc. of the thalamus. Their 
anatomical links thus make the 0T and NAc prominent members of 
the forebrain limbic system. On the basis of marked identities 
in histomorphologic appearance it has been suggested that the 
"ventral striatum" and its projection to substantia innominata 
are the limbic equivalent of caudate-putamen and its projection 
to globus pallidus. The parallel between OT-NAc and caudate- 
putamen is futher enhanced by the projection to each of a 
specific DA pathway from the midbrain. The limbic nature of 
OT-NAc may be further emphasized by its afferent connection to 
the A10 group which lies in the ventral tegmental area of Tsai, 
part of Nauta's "midbrain limbic area" ( Nauta, 1958 ). 
The existence of two distinct ascending DA pathways allows 
for some modification of the unitary DA-motor-psychosis hypothes 
elaborated by Klawans. While striatal DA may be involved in the 
pathogenesis of psychosis, none of the data presented would be 

inconsistent with the parcelling of motor phenomena to the NS 
DA system and psychic phenomena to the ML system. This alter¬ 
native is attractive from the standpoint of the neural associations 
of the two systems. 
The very great incidence of a schizophrenic-1ike psychos¬ 
is in patients with temporal lobe epilepsy ( Slater et a 1., 
1963; Falconer, 1973 ) some of whose major characteristics are 
the production of behavioral automatisms, lip-smacking and 
chewing motions and olfactory hallucinations make the ML system 
seem a reasonable substrate for some of the motor phenomena 
( automatisms and buccolingual dyskinesias ) as well as for the 
development of psychosis. Furthermore, the ability to alter 
autonomic state and elicit sniffing, licking and tonic and 
clonic movements with stimulation of the amygdala adds to the 
data suggesting a possible motor role for the ML system. 
Amphetamine in large doses produces in rats a stereotyped 
behavior that has long been used as an animal model of psychos¬ 
is ( Janssen et al., 1961; Randrup and Munkvad, 1970 ). In an 
attempt to determine the possible roles of the NS and ML systems 
in psychosis it was attractive to attempt to determine their 
roles in the mediation of amphetamine induced stereotyped be¬ 
havior ( A I SB ). 

Amphetamine Induced Stereotyped Behavior ( AIS B ) 
and Amphetamine Induced Psychosis 
Amphetamine in moderate doses is capable of eliciting 
nondistractab1e, driven, rapid and repetitious forms of behavior 
in many species ( Randrup and Munkvad, 1967; Snyder, 1972 ). 
Snyder emphasizes that the common properties of these repet- 
ative motor sequences are their compulsiveness and their apparant 
purposelessness. These highly repetitive motor activities elicited 
by amphetamine appear to be species specific in lower animals- 
mice, rats, guinea pigs and cats - but become more individualized 
in primates. 
In rats administered 10 mg/kg i.p. of d-amphetamine. 
stereotyped activity becomes maximal about 50 min. after injection 
and continues for about 2 hrs. ( Fog, 1969 ). This stereotyped 
behavior is classically described as sniffing, licking and 
gnawing of the cage floor. Prior to the onset of stereotypy the 
rat shows the well known locomotor stimulant effect of am¬ 
phetamine, but as stereotypy begins locomotion ceases ( Randrup 
and Munkvad, 1970 ). 
When administered amphetamine, pidgeons peck; cats exhibit 
sniffing and constant side to side looking movements and 
chimpanzees exhibit individualized repetitive activities such as 
side to side looking, self-picking and various more complex motor 
sequences. 

Stereotyped compulsive behavior has also been reported as 
a concomitant of amphetamine psychosis in man ( Scher, 1966; 
Rylander, 1966; Kramer et a 1., 1967 ). These activities may be 
of a highly individualized nature such as sorting out of a 
handbang's contents over and over again, or taking apart and 
reassembling watches or motors. Various bucco-1ingua1 dyskinesias 
have also been described as associated with amphetamine psychosis 
( Ashcroft et al., 1965; Connell, 1966; Mattson and Calverly, 
1968 ). Both auditory and visual hallucinations have been 
reported in amphetamine psychosis ( Ell inwood, 1967 ), but as 
Snyder points out ( Snyder 1972 ) the reports of visual hallu¬ 
cinations are more common in those cases where psychosis was 
precipitated by a single large dose of amphetamine than by 
long term low dose abuse, just as they are more characteristically 
seen in acute schizophrenic decompensations than in chronic 
psychosis without drugs ( Chapman, 1966: Bowers and Freedman, 
1966 ). Olfactory hallucinations are also characteristic 
of amphetamine psychosis, reported by 70% of the former 
amphetamine addicts that had experienced psychotic episodes 
interviewed by Ellinwood ( 1967 )- Finally, tactile hallucina¬ 
tions are also very common with amphetamine psychosis and 
they are frequently accompanied by delusions of parasitosis and 
compulsive rubbing, picking and scratching of the skin not unlike 
that of the stereotypies seen with lower animals. 
Amphetamine has precipitated psychoses in volunteers after 

one day of frequent oral doses ( Griffith, 1972 ) and within 
one hour after large i.v. dosage ( Bell, 1973 ). The psychoses 
would thus seem to be a direct effect of the drug and not 
the result of sleep deprivation or concurrent drug abuse of 
psychedelics or barbiturates. As has been mentioned, the 
psychosis responds to phenothiazines. It is also worth noting 
that the onset of the psychosis, which is invariably of a 
paranoid nature, is rather abrupt and is immediately preceded 
by a cessation of motor activities and a period of withdrawal 
not unlike the cessation of locomotor stimulation with the 
onset of AISB in rats ( Ellinwood, 1967; Griffith, 1972 ). 
Evidence for the mediation of AISB by CNS Dopamine 
The depletion of central catecholamines by the adminis¬ 
tration of C< -methy1-p-tyrosine, (AMPT), a tyrosine hydroxylase 
inhibitor, prevents the induction of both locomotor stimulation 
LS, and stereotyped behavior by the subsequent administration 
of amphetamine to rats ( Randrup and Munkvad, 1966; Weissman 
et al,, 1966 ). Administration of L-Dopa and an MAO inhibitor 
produces a stereotyped behavior like that seen with amphetamine 
This effect is not altered by DDC, a depletor of NE by DA-7U- 
hydroxylase inhibition, but is prevented by AMPT ( Scheel- 
Kruger and Randrup, 1967 ). FLA-63, another DA-^-hydroxy1ase 
inhibitor, is capable of decreasing hypermotility induced by 

d-amphetamine in mice ( Svensson, 1971 ) but does not alter 
AISB in rats ( Ayhan and Randrup, 1972 ). 
It would thus seem that the LS effect of d-amphetamine re¬ 
quires the presence of functional pools of NE, but that AISB 
requires only DA. Consistent with this is the finding that 
imipramine, which blocks reuptake by NE terminals but not by 
DA terminals, potentiates the LS response of high dose L-Dopa 
but not the induced stereotypy. ( Friedman and Gershon, 1972 ). 
Another approach to determining which of the CNS cat¬ 
echolamine systems mediates AISB has been the attempt to cor¬ 
relate behavioral differences of the d and 1 isomers of 
amphetamine with their specificities for NE and DA systems. 
Coyle and Snyder (19&9) reported that d-amphetamine-is 
10 times as potent as the 1 isomer in inhibiting reuptake of 
catecholamines into synaptosomes from nonstriatal brain tissue, 
while on striatal synaptosomes the two isomers are equipotent 
in blocking uptake. These results were confirmed ( Taylor and 
Snyder, 1970 ) in studies of the uptake of - NE into brain 
slices after amphetamine pretreatment of the rats. Again, d 
and 1 were equipotent in blocking uptake into striatum. 1 was 
ineffective in other brain regions however, whereas d showed 
significant block of uptake into brainstem, cerebellum and 
diencepha1 on. D was also effective in depleting endogenous 
NE stores whereas 1 was not. In behavioral studies rats were 
pretreated with the MAO inhibitor iproniazid and the ED^g 

for LS and AISB determined for the two isomers. The endpoint 
for determination of AISB was chewing, licking and gnawing re¬ 









again confirming a 10 times greater potency of d-amphetamine 
on locomotor stimulation - thus indicating a primary NE mediation, 
but only a 2:1 difference of their potencies for AISB - which it 
was concluded demonstrated a predominant role of DA in mediating 
AISB, with perhaps some minor NE effect. 
Further evidence for a primary role of DA in the mediation 
of AISB comes from the observation that apomorphine, a direct DA 
receptor agonist ( Anden et al., 1967 ),can also produce a 
stereotyped compulsive gnawing syndrome in rats ( Harnack, 
187^; Ernst, 1966 ). Apomorphine has been shown to mimic 
amphetamine in its ability to decrease the firing rate of 
dopaminergic neurons, but does not alter the firing of NE cells 
in the locus coeruleus ( Bunney, 1973 ). The cessation of 
firing is caused by apomorphine even after the administration of 
AMPT which prevents the effect of amphetamine on these cells. 
While sedative hypnotics have no efficacy whatever in 
blocking AISB, the antipsychotic neuroleptics do. In fact, the 
ability to block AISB has been used as a screening test for 
possible new antipsychotic agents ( Janssen, 1961 ). Promazine, 

a phenothiazine devoid of antipsychotic activity does not block 
AISB ( Del Rio and Fuentes, 1969 ) and in general the anti¬ 
psychotic potency of a drug seems to parallel its ability to 
block AISB. Clozapine, a potent new antipsychotic, however, 
has been reported to display only a very weak antagonism of 
AISB ( Stille and Hippius, 1971 ). It is of particular note 
also that this drug has been reported to be free of extra- 
pyramidal side effects. Furthermore, Anden ( 1973 ) has reported 
that clozapine effects limbic DA metabolism to a greater extent 
than it does striatal DA metabolism, whereas ha 1 operiodol, an 
antipsychotic with prominent extrapyrami da 1 side effects is 
equipotent on limbic and striatal DA metabolism. Such dif¬ 
ferences might be attributable to a differential blockade of 
limbic and striatal DA receptors. It thus becomes possible 
that the antipsychotic and extrapyramida 1 effects of the 
neuroleptics may be separable, and that AISB may be a more 
accurate model for extrapyrami da 1 effects than psychosis. 
Further evidence to suggest that AISB may be a better 
model for extrapyramida 1 motor effects than psychosis comes from 
looking at the effect on AISB of alterations in CNS acetyl¬ 
choline. It is standard practice in this country to use anti¬ 
cholinergics for the alleviation of the extrapyramida 1 symptoms 
induced in schizophrenics by their neuroleptic medications. 
Kline and Davis (1969) go so far as to recommend the pro¬ 
phylactic use of anticholinergics in patients receiving anti¬ 
psychotic medications, and it is the general consensus that such 
treatment does not alter the antipsychotic potency of the 

medications. Even a report to the contrary ( Singh and Smith, 
1973 ) found that while it is possible that administration of 
benztropine may have reversed the effect of antipsychotics in 
promoting ease of social functioning, it did not appear to have 
any significant effect on either thought disorder or hallucinations. 
Thus it seems possible to ameliorate the motor effects of the 
neuroleptics by the use of anticholinergics without altering 
their antipsychotic effect. Anticholinergics have been shown to 
decrease, and anticholinesterase inhibitors to increase,the 
threshold dose of d-amphetamine required to induce stereotyped 
behavior. ( Fog et al., 1966; Janowski et al., 1972; Klawans 
et al., 1972 ). Thus, with respect to its response to manipula¬ 
tions of cholinergic tone AISB appears more closely correlated 
with the motor effects of the neuroleptics than it does with 
the antipsychotic effects. 
Perhaps then if the antipsychotic and extrapyrami da 1 effects 
of the neuroleptics are pharmacologically separable they may 
also be anatomically separable and reflect the differential 
activities of these agents on the two ascending dopamine pathways. 
Anatomic Substrate of AISB 
Attempts to determine which of the two DA pathways mediates 
AISB have been inconclusive. Those studies in which DA, amphetamine, 
apomorphine or other drugs have been stereotaxica11y implanted 
into the striatum ( Ernst and Smelnik, 1966; Fog et al., 1967; 

Fuxe and Ungerstedt, 1970 ) while they have all concluded that 
striatal DA mediates stereotypy may be criticized on 2 counts. 
1) It is difficult to control for diffusion of the substance 
from the head of the caudate to the nuc, accumbens which is 
rostro-ventra1 1 y contiguous with it. 2) The high concentrations 
of the drugs thus presented are most unphysiologic. 
Lesions of the corpus striatum have been reported to reduce 
or abolish the stereotypies induced by amphetamine and apomor- 
phine ( Amsler, 1923; Fuxe and Ungerstedt, 1970; Anden, 1970; 
Naylor and Olley, 1972 ). Since there is evidence that stereo¬ 
typed behavior is mediated by CNS DA and the striatum contains 
the largest concentration of DA in the brain, it has been con¬ 
cluded that the above lesions produce their effect by destroying 
striatal dopamine receptors. Aside from the lack of substantial 
histological proof of the specificity of these lesions ( to rule 
out involvement of NAc or the ML pathway ) a second objection 
to the above conclusion may be made. Gross electrolytic lesions 
destroy more than just the DA containing cells or their receptors. 
It is not impossible that the caudate, whose importance in the 
control of movement is well known, may be secondarily involved 
in the patterning of movements whose inception may be due to DA 
stimulation in the limbic areas. If this were the case then lesions 
of the striatum might block stereotypy not as a result of loss of 
striatal DA but by the alteration of the efferent processing of 
limbic DA activity. 

Simpson and Iversen ( 1971 ) electro1ytica11y lesioned the 
substantia nigra bilaterally and did not observe a diminishment 
of A1SB. In a subsequent experiment however, ( Creese and 
Iversen, 1972 ) when 6-hydroxydopamine ( 6-OHDA ), which specifica 
destroys catecholamine containing cells while sparing other 
neural tissue ( Ungerstedt, 1968; Bloom et al., 1969 ) was 
stereotaxi cal 1y injected bilaterally, intra-cerebra11y into 
the area just medial to the medial lemniscus in the midbrain, 
stereotypy to amphetamine was abolished. While Iversen con¬ 
cluded from this that it was the loss of striatal dopamine that 
prevented the occurence of AISB, it is obvious from the position 
of her cannula tip at injection that she must have lesioned 
both the NS and ML pathways since the two run together as they 
ascend through this area. 
Finally, it was reported by McKenzie ( 1972 ) that removal 
of the olfactory tubercle bilaterally, but not of the striatum, 
resulted in the diminishment or absence of stereotypy to 
apomorphine in rats. 
Thus, despite the voluminous published work on the subject, 
it is still uncertain 1) whether AISB is in fact a valid animal 
model of psychosis, and 2) whether AISB is mediated by the NS 
or ML DA pathways. 
It thus seemed worthwhile to investigate further the roles 
of the NS and ML pathways in the mediation of AISB. Preliminary 
experiments were performed to delineate more precisely the be¬ 
havior described as stereotypy and its response to some pharma- 

cologic manipu1 ations aimed at delimiting the respective roles 
of DA and NE in this behavior. After this, experiments were 
performed in which lesions were made of DA terminals in the fore¬ 
brain by the intracerebral injection of 6-OHDA into either the 
corpus striatum or olfactory tubercle, and the subsequent 
response of the animal to amphetamine observed. While previous 
investigations have at most measured whole brain DA content 
as proof of the efficacy of lesion this has not allowed for con¬ 
firmation of the specificity of the lesion. In these experiments 
advantage was therefore taken of the technique of histflourescent 




Male, albino Sprague Dawley rats weighing 230-270 grams 
were used in all experiments. Rats were fed a diet of Purina 
rat chow ad lib. Those rats who were lesioned in the caudate 
were tube fed with a 1:1 solution of sweetened condensed milk 
and water for one week after operation. For drug studies rats 
were used once and sacrificed. 
The following drugs were used in the experiments: 
d-amphetamine sulfate ( varying doses as specified ), routine 
behavioral testing with lOmg/kg 
1-amphetamine sulfate ( varying doses as specified ) 
pargyline hydrochloride ( 100 mg/kg ) 
apomorphine hydrochloride ( varying doses as specified, 
routine behavioral testing with 5 mg/kg ) 
phenoxybenzamine ( 20 mg/kg ) 
clonidine hydrochloride ( 3 mg/kg ) 
All drugs were dissolved in distilled water and injected 
i .p. 
Behavioral testing was carried out as discussed in the section 
on Stereotyped Behavior-Scoring System. 
Animals to be lesioned were anaesthetized with chloral 
hydrate and mounted in a Kopf stereotaxic. 6-hydroxydopamine 
dihydrobromide was dissolved in distilled water with ascorbic 
acid .1 mg/ml to give a concentration of 5ug ( free base )/ul. 

The solution was injected through a 25u1 Hamilton syringe at a 
rate of lul/min. The solution was always used within 3 days of 
preparation and never after any color change. 
Preliminary experiments led to the establishment of coordin¬ 
ates for lesions as follows: 
for lesions of the olfactory tubercle, skull landmarks 
were - anterior, bregma + 0.9mm.; lateral, 1.6mm.; 
vertical, 8.8mm. ( from skull surface ). These co¬ 
ordinates were found to correspond to a placement according 
to the atlas of Konig and Klippel ( 1963 ) of approx. 
A 7^70u, L 2mm. and V -2.7mm. 
lesions were also placed in the head of the caudate 
both centrally and dorsolatera11y with coordinates 
according to Konig and Klippel of approximately A 8380, L. 
2.4mm, V + 0.4mm and A 8380, L 3.5mm, V + 1.0mm respectively. 
A few lesions were also made in the region of the ML 
bundle which was found to correspond to a position of 
A 7470, L 2.1, V-1.4. 
All lesions were bilateral with 40ug of 6-0HDA injected 
into each side. After lesioning the animals were kept for two 
weeks to allow for adequate degeneration before behavioral testing 
was performed. 
After behavioral testing the lesioned animals were de¬ 
capitated, and the brains quickly removed. Cuts were made through 
the brain with a razor in the frontal plane at the most rostral 

and caudal extents of the olfactory tubercle visible on the 
ventral surface. This tissue was then removed and quickly 
frozen in liquid propane-propylene in preparation for histo- 
flourescence microscopy according to a modification of the 
formaldehyde condensation technique of Falk as previously des¬ 
cribed ( Aghajanian and Asher, 1971 ) • 
Estimates of the extent of DA depletion from the caudates 
were made as follows: 
The volume of the head of the caudate from its most 
rostral extent to the frontal plane of 7190 ( the caudal limit 
of brain examined ) was calculated from the atlas of Konig and 
Klippel. This came to approx. 18.3 mm^ ( unilateral ). The 
degree of loss of flourescence was taken as a measure of the 
degree of loss of DA from the structure since DA accounts for 
essentially all the flourescence of the caudate. 
The caudate and OT-NAc in nonlesioned animals are normally 
marked by quite intense green flourescence of their native dopamine. 
( See figures 3 £- 4 ) . In lesioned animals however, this flourescence 
was markedly depleted. ( See figures 3 & 4 ). 
The extent of flourescence depletion was judged subjectively. 
Remaining areas of nondepleted caudate or tubercle were used 
as internal standards of 100% intensity of flourescence. Cortex 
was examined in each slide for determination of the background 
ffourescence, rated 0%. Partially depleted areas of caudate or 
OT-NAc were rated as 25%, 50% or 75% intensity of flourescence 

as compared to the internal standards of 100% and 0%. 
The regions of absent or partial flourescence of caudate 
in slides at several rostro-cauda1 levels were mapped out and 
used to calculate a depleted volume. The percentage intactness 
of flourescence, as compared to a nonlesioned animal, was 
then calculated by dividing the nondepleted volume by the 
estimated real volume of 18.3. This number thus represented 
an approximation of the percentage flourescence, and pre¬ 
sumably percentage of DA, of caput caudati in the lesioned 
animal as compared to that of a nonlesioned animal. A similar 
method was used for estimation of flourescent depletion of 
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Legends to Figs 3 and 4 
Comparison of Histoflourescence in control and 
6-OHDA lesioned animals 
Fig. 3) Histoflourescent micrographs of olfactory tubercle ( 100X ) 
A) bright flourescence of nonlesioned animal 
B) absence of flourescence in animal lesioned with 6-OHDA 
in the olfactory tubercle 
Fig. 4) Histoflourescent micrograph of caudate nucleus ( 60X) 
A) bright flourescence of nonlesioned animal 
B) marked depletion of flourescence in animal lesioned 
with 6-OHDA in the caudate nuc. 

Stereotyped Behavior - Scoring System 
Probably the most difficult problem encountered in the 
investigation of stereotyped behavior is that of defining and 
quantitating the phenomena observed. Snyder has noted stereo¬ 
typy to be a "nondistractab1e, driven, rapid, and repeti fcious" 
sequence of motor activities. On a gross level such behavior is 
strikingly apparant to even the most unsophisticated observer. 
But to date no uniform criteria have been established for the 
scoring of this behavior in rats, and in the various investigations 
of A1SB a vast multiplicity of scoring schemes has been used. 
Harnack ( 187^> ) was the first to describe the stereotypy 
evoked in rats by apomorphine. Ernst has used the apomorphine 
induced "compulsive gnawing syndrome" as the primary focus 
of his investigations. Randrup and Munkvad on the other hand 
have been investigating the nature chiefly of amphetamine 
induced stereotypies. Though it has been pointed out that there 
is a qualitative difference in the stereotypies evoked by the 
drugs ( Fog, 1 969 ) the compulsive gnawing so characteristic 
of apomorphine has also frequently been used as an endpoint for 
tests of AISB. Since the mechanism of action of these two drugs 
is different and since amphetamine would stimulate NE and perhaps 
5-HT systems as well as DA^while apomorphine would theoretically 
produce its effect on the DA system alone, it would not be un¬ 
expected for the behavior elicited by the two drugs to differ. 
Randrup and Munkvad ( 1970 ) have succinctly described 

the amphetamine induced behavior - 
The behavior we describe as stereotypy is seen very clearly 
in rats during a period about 1 to 2 hrs. after subcut¬ 
aneous injection of 10 mg/kg d-amphetamine sulfate. 
The behavior consists of continuous sniffing, licking 
or biting of the cage floor or the animals own forelegs. 
The rat sits in a crouched posture and usually presses its 
body against the cage wall. Normal activities such as 
grooming, eating, rearing and forward locomotion are 
absent; backward locomotion is occasionally seen. This 
behavior is preceded and followed by periods of less 
complete stereotypy ( sniffing is increased but inter¬ 
rupted by some other activities ), which is also observed 
after small doses of amphetamine. 
Lai and Soukes ( 1973 ) have described the apomorphine 
stereotypy to 5 mg/kg. 
Almost immediately after the injection of apomorphine 
continuous sniffing, licking and, in cages with suffic¬ 
iently large grid size, biting developed. Initially 
some of the sniffing was directed upwards, with the 
animal rearing on its hind legs, but within 5 min. this 
was almost entirely directed towards the floor. Initially 
there was an increase in forward locomotion accompanying 
the compulsive behavior but within 10 min. normal activ¬ 
ities such as grooming, social interaction and forward 
locomotion rarely occured. By this time ptosis was fully 
developed. In the terminal 10 min. there was a gradual 
return of normal activities interspersing the SB and 
diminution of ptosis until the animals grouped together 
and fell asleep or rested quietly. 
One of the major differences in the descriptions above 
is that of the time of onset of stereotypy. There is also 
the ptosis noted with apomorphine, while amphetamine is 
usually noted to produce proptosis and wide palpebral fissures. 
While the two behaviors are similar they are also different. 
Is this due to a difference in relative drug potency on DA 
systems or is this due to a difference in monoamine involvement 
by the two drugs? 

Janssen ( 1961 ) in testing the efficacy of neuroleptics 
to block AISB used compulsive gnawing as his endpoint, as have 
many others including Snyder and Coyle ( 1969 ) in their compar¬ 
ison of the d and 1 isomers. Attempts to quantitate intermed¬ 
iate grades of stereotypy have led to several different scoring 
systems ( del Rio and Fuentes ( 1969 ); Ernst ( 1966 ); McKenzie, 
1972; Naylor and Olley, 1972 ) in which the degree of drivenness, 
continuity and nondistractabi1ity of gnawing and licking behavior 
has been the major parameter quantitated. Other schemes 
( Naylor and Olley, 1972 ) while similar also take into account 
the appearance of "small head movements". Creese and Iversen 
( 1972 ) quantitated the number of these small head movements 
/min. as their sole measure of AISB. There have thus been 
differences in the behaviors measured by various investigators. 
It becomes critical for the investigator to specify precisely 
what in fact he is measuring. 
Animals in this experiment were observed for stereotypy 
by placing them in wire mesh cages 36 x 20 cm, two animals to 
a cage. They were allowed to acclimate to the cage for 20 min. 
after which drugs were administered. Each animal was observed 
for about 5 min. before rating its behavior at any given time 
point. The highest level of stereotypy shown by the animal 
during that time was given as the animal's score at that time 
point, unless the animal very clearly alternated rather equally 
between two levels during the 5 min. of observation, in which 
case both grades were scored and an intermediate grade used for 

ca1cu1 ations. All animals were scored by the investigator. Animals 
3*0 
were generally scored at 30, 60, 90 and 120 min. after injection 
of amphetamine and at 5 to 15 min. after apomorphine. On the 
basis of observations of many animals at several dose levels the 
following scoring system was arrived at and used in all experiments. 
Stereotyped Behavior 
Grade 0) Animal rests quietly, occasionally performing 
brief exploratory activities with discontinuous 
sniffing. 
Grade EA) Animal is continually absorbed with exploratory 
activity - constantly ambulating around his cage 
and sniffing. 
( Scored numerically as grade 0 ) 
Grade 1) Animal sniffs the air with head raised, often 
moving his head in a circular manner such that 
his nose describes a circle in the frontal plane. 
His feet are fixed in position and he is immobile 
while performing this behavior, - but this behavior 
is often interspersed with mobile exploratory 
activity. 
Grade 2) Animal bends his head so that his nose is now 
down to the cage floor. He moves his head from 
side to side, all the while sniffing. This 
activity may be performed with either wide or 
narrow lateral excursions of the head, may be 

quite rapid or slow, and may or may not involve 
the poking of the animal's nose through the floor. 
Grade 3) Animal continues behavior as in 2), but now 
begins to intermittently lick and or gnaw at 
the bottom of the cage. 
Grade k) Animal continuously gnaws or licks the cage 
bottom with total absence of ambulation. 
The degree of compulsivity, measured by the inverse of 
the time it took the animal to return to his former behavior after 
being distracted, generally increased with increasing grade score. 
This scoring scheme was found to generally reflect the temporal 
onset sequence of behaviors after a dose of amphetamine as well 
as the gradation of responses to different dosage levels. 
Two or three control animals were run in all experiments. 
Due to the very minor variation from day to day in response of 
control animals to 10 mg/kg of d-amphetamine or 5 mg/kg 
d-amphetamine plus pargyline, these controls from all experi¬ 
ments were grouped for final scoring. 
4 
Drug Studies 
Some preliminary experiments were run in order to deter¬ 
mine an optimum dose of d-amphetamine for behavioral testing 
and also to gain some insight into the relative roles of the 
various monoamines in the mediation of AISB. 
1) d and 1 amphetamine with MAO inhibition 
Many reserachers have used MAO inhibitors to strengthen 
the observed stereotypy to amphetamine. In this first series 
of tests varying doses of d ( 2.5 and 5 mg/kg ) and 1-amphetamine 
( 5, 7 1/2, 10 and 15 mg/kg ) were administered to animals two 
hrs. after the prior injection of pargyline hydrochloride 
( 100 mg/kg ). Animals were scored at 30, 60, 90, and 120 min. 
after the injection of amphetamine. The individual scores 
of the animals at each time period were summed and divided by 
the number of animals to arrive at an average group score. Each 
animal was used once and sacrificed. 
Results are shown in figures 5 and 6. 
The results of this experiment agree temporally with pre¬ 
vious reports, stereotypy becoming maximal in the second hr. 
post injection. Taylor and Snyder ( 1970 ) however reported 
an ED50 for AISB to the 1 isomer of 8.8 mg/kg. In this test 
only one out of five animals showed any significant stereotypy 
at 10 mg/kg of 1-amphetamine, and even at 15 mg/kg of the 1 
isomer the intensity of oral activity ( licking and gnawing ) 
was not as marked as that after 5 mg/kg of the d isomer. 

AI.SR to d and 1 isomers of amonetamine in varyi7-1 £ doses 
after prior ad mini strati, on of pargyline 100 mr/k^, 
?. hrs earlier 
that time 
each point represents the average stereotypy grade score of 
all animals scored at that time ± 3.E.M. 

Of particular note is that all animals administered 1- 
amphetamine at 5 and 10 rpg/kg exhibited a peculiar periodic 
staring behavior in which the animals would remain immobile, 
with eyes widely dilated and proptotic but not responding to 
visual threat. This behavior was also marked by some at least 
moderate degree of catalepsy as determined by the animal leaving 
a rear leg propped up by a cork for 1 to 2 min. The cataleptic 
nature of the behavior was difficult to determine however due 
to the periodic nature of the appearance of the behavior for 
30 sec. to 2 to 3 min. at a time interspersed with the animal's 
more normal stereotypyed or other activities. It was further 
noted that in those animals spontaneously demonstrating this 
behavior, the behavior could be induced and intensified by pre¬ 
senting the animal an auditory stimulus ( hand clapping etc. ), 
immediately after the cessation of which this behavior would 
be prominently displayed. This behavior was not observed with 
the higher dose of 15 mg/kg of 1-amphetamine and not in any 
of the animals administered the d isomer in this experiment. 
The usefulness of MAO inhibitors for investigations into 
the mechanism of action of amphetamine in AISB might however 
be questioned. Such pretreatment alters the function of all 
CNS monoamine systems, not just DA, and may thus become a 
confounding factor in attempts to determine the role any one 
particular system in this behavior. To avoid this possible 
problem it was decided to use amphetamine without prior MAO 

inhibition in all the remaining experiments. 
2) d and 1 amphetamine without prior MAO inhibition 
The results of administering varying doses of d ( 5, 
7-5, 10 and 15 mg/kg ) and L ( 10, 20, 25, and 30 mg/kg ) 
amphetamine to rats without pargyline pretreatment are seen 
in figures 7 and 8, 
Comparision of figures 5 and 6 with figures 7 and 3 show 
that pargyline did indeed bring on stereotypy faster and stronger 
than in nonpretreated animals. Pargyline pretreated animals 
given 5 mg/kg of d-amphetamine showed a maximum stereotypy 
of 3-5 at 60 rnin, post injection, while nonp ret reated animals 
with this dose showed a maximum stereotypy of only 1.5 at 
90 min. It might also be noted that the low doses of 1-amphetamine 
did not alter the normal social interaction of the animals in 
a grouped situation ( huddling ), which was blocked by all 
doses of d-amphetamine. 
Figures 9 and 10 show dose response re 1 ationships of AISP 
to the d and 1 isomers for the nonpretreated animals. The re¬ 
sults show a minimum ration of 3:1 in the efficacy of d; 1 in 
inducing stereotypy. The greatest change in responsiveness to 
d occured between 5 and 7-5 mg/kg and for 1 between 25 and 30 
mg/kg (figure 7)- The ED50 for production of grade 3 stereotypy 
or above was between 5 and 7-5 mg/kg for the d isomer and approxi¬ 
mately 25 mg/kg for the 1 isomer ( figure 8 ). A similar ratio 
of 3-^:1 seems also to hold from this data for the efficacy of 
d;l to elicit grade 2 stereotypy or better. These results disagree 
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with the 2:1 ration found by Taylor and Snyder ( 1971 ) but do 
agree with the 3-i+:l difference in potencies of d:l amphetamine 
in stimulating release from DA synapses in vivo in the rat as 
reported by Von Voigtlander and Moore ( 1973 )• Further 
examination of this finding appears in the final discussion. 
3) d-amphetamine with phenoxybenzamine pertreatment 
It has been well demonstrated that amphetamine can induce 
stereotyped behavior in the absence of CNS NE. It has not 
however been noted whether such stereotypy is changed temporally 
or qualitatively from that seen in normal animals. 
Del Rio and Fuentes ( 1972 ) reported that concommitant with 
their reversal of stereotypy, neuroleptics also produce a return 
of locomotor stimulation after amphetamine. This finding may 
bear directly on the problem of the latency of onset of AISB 
as opposed to that induced by apomorphine. Taylor and Snyder 
( 1970 ) have suggested that AISB is predominantly DA mediated 
whereas locomotor stimulation seems to be predominantly NE 
mediated. It would be possible for the initial hyperactivity of 
animals after amphetamine to represent a period of NE dominance, 
replaced after a period of about one hr. by a switch to a state 
of relative DA dominance manifested by the onset of stereotypy. 
Thus by administering neuroleptics that would block DA receptors, 
Del Rio and Fuentes were able to return the animals to an NE 
dominant state and observed the return of locomotor stimulation 
which would normally have been replaced by stereotypy at the 
time. It would seem reasonable from this hypothesis to expect 

that if NE activity were blocked, and amphetamine thus led to DA 
stimulation alone, the stereotypy observed might be more similar 
to that seen with apomorphine. 
To test this hypothesis 5 rats were pretreated with 
phenoxybenzami ne, an <p( -adrenergic blocking agent ( Anden et 
al., 19o7 ), 20 mg/kg i.p,, 20 min. before testing of the animals 
with d-amphetamine 10 mg/kg. 
Results are seen in figure 11. 
The average stereotypy grade score for the phenoxybenzamine 
pretreated animals was significantly greater ( p<.05. Student's 
t test ) than that of the nonpretreated animals at 30 min. 
Furthermore, the intensity of the gnawing behavior in the pre¬ 
treated group was considerably greater than thr>t seen in 
animals administered amphetamine alone. ( At 90 min. this difference 
was significant at level of p .01 ) Thus, this preliminary 
experiment was consistent with the hypothesis that the delay in 
onset of AISB is due to an initial NE predominance. 
In a further test of this hypothesis rats were administered 
clonidine, a potent NE receptor agonist ( Anden et al., 1970 ), 
at a dose of 3 mg/kg. Three rats received the clonidine 30 min. 
prior to injection of d-amphetamine 10 mg/kg and three more rats 
received the clonidine 30 min. after injection of the amphetamine. 
Pretreatment with clonidine did not slow the onset of stereotypy nor 
did it diminish stereotypy when administered to animals after 
amphetamine. In fact, all the six animals after having received 
both clonidine and amphetamine demonstrated the most intense 
gnawing behavior witnessed by this investigator. It might be 
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Comparison of AI SB to d-amphretamine 10 mg/kg 
with and without phenoxybenzamine pretreatment 
rhenoxvbenza.mi ne 20 mg/kg administered 20 min. before 
amnheta.ini ne 
Differe from nonrretreated animals at level of 
r> < .Of ( students t-test) 
Differs from nonpretreated an-imal s at level 
p <.01 ( students t-test) 
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noted also that those animals administered clonidine after 
amphetamine exhibited after clonidine injection extreme hyper¬ 
activity - often jumping right out of the cage. This hyper¬ 
activity lasted for approximate 1 y 40 min. and ''as accompanied 
by intense gnawing activity. 
Naylor and 31 ley ( 1972 ) have reported that lesions of the 
nuc. lateralis amygdaloideus, which receives NE but not DA 
innervation, led ;o a reduction of gnawing behavior elicited 
in rats by apomorphine. The above results with clonidine would 
agree with a stimulatory role for NE in gnawing behavior, but do 
not readily agree with the hypothesis relating delayed onset 
of AISB to initial NE dominance. The actions of clonidine seem to 
be multiple however. While it is a direct NE receptor stimulant 
in the mg/kg dosage range, it also appears to be most potent 
( ug/kg ) in stopping the firing of NE cells in the locus 
coeruleus by a direct effect on these cells. ( Aghajanian, per¬ 
sonal communication ). It is thus difficult to draw any firm con¬ 
clusions from the above findings. It does seem however clear 
that though NE may not be necessary for amphetamine to induce 
stereotyped behavior, altering the level of NE activity can 
effect the quality of the stereotypy observed. 
4) Role of 5-HT in AISB 
Though no experiments were performed in this study to 
specifically elucidate the role of serotonin in AISB it seems 
worthwhile at this point to mention some of the work done on 
this problem. 
Ernst ( 1972 ) has reported that pretreatment of rats with 

parachloropheny1alanine, a specific serotonin depleting agent 
( Koe and Weissman, 1966 ), did not alter the stereotyped behavior 
elicited by d-amphetamine ( 1 mg/kg ) and MAO inhibition. Thus, 
he concluded that the DA effect to produce AISB was not mediated 
through 5-HT. McKenzie ( 1973 ) however has reported some 
preliminary findings in which electrolytic lesions of the mid¬ 
brain raphe nuclei, site of the 5-HT containing cell bodies 
( Dahlstrom and Fuxe, 1965 ), blocked the appearance of apomorphine 
induced stereotyped gnawing, without altering licking or sniffing. 
Cools ( 1973 ) has found that injection or 1Oug 5-HT into the 
antero-ventral caput caudati of the cat produced intense 
choreoathetosis and self-directed activities. 5-hydroxytryp- 
tophan, the immediate precursor of 5-HT, is capable of eliciting 
in MAO I pretreated rats a fierce compulsive gnawing syndrome 
( E^nst, 1973 and personal observation ). This behavior is 
unlike that induced by amphetamine in that the animal holds his 
teeth clamped over the mesh wire for prolonged periods of time 
while performing choreoathetoid movements of his front paws. 
This behavior is directly attributable to serotonin since it is 
not altered by prior depletion of catecholamines by AMPT ( Ernst^ 
1972 ). Thus, though 5-HT is not necessary for AISB it seems 
possible that alteration of central 5-HT activity may modify 
the type of stereotypy observed. Evidence has also accumulated 
to suggest that central 5-HT may exert an inhibitory influence 
on the locomotor stimulatory effect of amphetamine ( Mabry and 
Campbell, 1973 ). If 5-HT should prove antagonistic to NE in 

the inducement of locomotor activation, this might provide yet 
another means by which 5-HT might alter stereotypy. It should 
also be noted that the doses of amphetamine (> 5 mg/kg ) required 
to induce SB are capable of depleting the extra granular stores 
of 5~HT in the terminals of serotonergic neurons ( Fuxe and 
Ungers ted t, 19/0 )• 
5) Stereotypy to low doses of apomorphine 
It was of further interest to examine the nature of the 
behavioral response to apomorphine in low doses. It is known 
that apomorphine induced stereotypy has a log-dose relationship 
( Lai and Sourkes, 1973 ), but the qualitative nature of the response 
to sub and nearthreshold doses has not been described, 
Apomorphine HCL was administered to 3 animals each, in earh 
of three doses levels -1,2 and 3 mg/kg. The 3 animals receiving 
1 mg/kg showed sniffing, elevation of their heads and periodic 
immobile staring behavior. At 2 mg/kg there was a greater diver¬ 
sity of effects. 1 animal showed level 2 stereotypy with eyes 
closed and occasional gnawing motions of its mouth: 1 animal 
showed sniffing of the air with head elevated, rearing against the 
cage wall and periodic staring behavior; the last animal al¬ 
ternated equally between grade 3 stereotypy and periodic staring 
behavior. At 3 mg/kg all animals showed the normal stereotypyed 
compulsive gnawing snydrome with marked ptosis. 
It was surprising to find that subthreshold doses of 
apomorphine elicited the same periodic staring behavior seen with 
low doses of 1 amphetamine after pargyline pretreatment. It was 

possible to induce reduced levels of SB to apomorphine by 
the administration of very low doses. 

Result of Lesions 
Initial attempts to obtain specificity in lesions of the 
ML or NS pathways by intracerebral injection of 6-OHDA into the mid¬ 
brain were unsuccessful. Due to the closeness of the structures 
and diffusion of the injected solution both pathways were always 
effected. This led to the attempt to lesion the terminal areas 
of the two systems where the spatial separation of structures would 
not make diffusion of the injection so critical. Injections of 
6-OHDA into the head of the caudate, the olfactory tubercle 
and the mesolimbic pathway were performed bilaterally as 
described in methods. 
Examination of the histoflourescent brain sections of 
operated animals revealed; 
1) Necrosis around the injection site of the 6-OHDA at the 
2 
cannula tip encompassed an area of about 0.3 Tim in its 
greatest extent. This area showed marked generalized tissue 
necrosis and a large amount of orange autof1ourescence. 
2) Catecholamine f1ourescence about this necrotic area was 
greatly reduced to varying extents depending upon the 
precise location of the injection. In general an area 
2 
of at least 2.0 mm immediately around the injection site 
would be totally devoid of catecholamine flourescence. Sur¬ 
rounding area would be partially depleted. The specificity 
of the 6-OHDA for catecholamines was evidenced by the fact 
that in areas totally depleted of green catechol amine 
flourescence the yellow specks of 5-HT terminals were 

still observed. 
3) When the cannula tip was in the region of a fiber bundle 
the injected 3-OHDA had a tendency to diffuse along the 
length of the fiber bundle. Thus, the anterior commisure 
and the "pencil bundles" of Wilson were often marked by 
O'-ange autofl ou rescent material for considerable lengths 
after injections into the tubercle and caudate respectively. 
Thus, the intracerebral injection of a large amount of 
6-OHDA ( AOug ) produced a sorprising1y small degree of gen¬ 
eralized necrosis and was capable of depleting large areas of 
DA terminal regions. Due to the normal great intensity of green 
flourescence in the olfactory tubercle, nuc. accumbens and caudate- 
putamen^ the borders of depleted areas, though they gradually shaded 
off, were always readily discernable. 
Table 1 shows the results of 8 animals lesioned bilaterally 
in the olfactory tubercle. 
6 of the 8 animals showed significant loss of flourescence 
in the tubercle and accumbens. Only 3 animals ( 89-OA, 89-02, 
96-10 ) however, showed a reduced level of stereotypy when 
tested with d-amphetam i ne 10 rng/kg. These 3 animals all showed 
significant loss of striatal flourescence. 96-10, ^ith less 
than half the striatal flourescence present on one side and 
only about 10% on the other side did not stereotype at all 
with amphetamine. When tested with apomorphine 5 mg/kg 96-10 
and 89-02 showed the normal stereotyped compulsive gnawing. 
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f1ourescence from tubercle and accumbens while striatal 
flourescence was intact. These animals all stereotyped nor¬ 
mally to amphetamine. 
Animal 89-01 is the most clearcut of the group. This 
animal showed essentially total loss of flourescence in accumbens 
and tubercle with only the most minimal striatal involvement, 
( see figure/^.). This animal showed a normal high grade of 
stereotypy to amphetamine. It would appear then that DA in the 
olfactory tubercle and nuc. accumbens is not necessary for 
amphetamine to elicit stereotyped behavior. Graphic representations 
of the flourescence depletion of animals 89-01 and 89-0 as re¬ 
presentatives of this group are shown in figures/^and /J » 
It is of note that all those animals that did show great 
depletion of lirnbic DA demonstrated a peculiar staring behavior 
when administered amphetamine. This behavior was periodic 
in appearance and seemed identical to that seen with low 
doses of 1-amphetamine administered to normal rats after 
pargyline pretreatment. The rats were immobile with eyes markedly 
proptotic, not responding to visual threat. The behavior 
could be stimulated by auditory stimulation as described earlier. 
This behavior appeared for 1 to 2 minutes at a time interspersed 
with the animal's more normal stereotyped activities. 
Thus, depletion of DA from tubercle and accubens resulted 
in the appearance of a peculiar periodic staring behavior but 
did not prevent AISB. The dorsal diffusion of 6-0HDA iniected 
into the tubercle resulted in the depletion of varying amounts 

of striatal dopamine in several animals. Those animals with 
significant striatal depletion showed reduced levels of 
stereotypy. Animal 96-10 with the greatest amount of striatal 
depletion did not stereotype to amphetamine but did to apo- 
morphine. These results tended to indicate that it was striatal 
dopamine that was necessary for AISB. 
To test this hypothesis a second series of experiments 
was performed in which injections were made directly into the 
caudate nucleus as described in methods. 
Table 2 shows the results of bilateral injects of 6-0HDA 
into the caput caudati. 
Animals 96-05 and 96-07 showed total loss of flourescence 
in the striatum while the limbic areas were involved to varying 
extents. These animals did not stereotype to amphetamine. 
96-08 which was found to have 50% depletion of striatal flour¬ 
escence bilaterally and totally intact limbic flourescence did 
not stereotype to d-amphetamine. 96-09 which showed an inter¬ 
mediate level of caudate depletion also showed an intermediate 
level of stereotypy, varying between grade 1 and grade 3 through¬ 
out the time observed. 96-06 in which the caudate was not 
depleted of flourescence to any large extent showed a normal 
stereotyped response to d-amphetamine. Graphic representation 
of h i stof 1 O'J rescence of animals 96-05 and 96-03 as representati ves 
of this group is shown in figures 14 and 15. 
Thus^, i t was possible by depleting 50%, of the striatal DA, 
without any involvement whatever of the limbic areas, to 
completely abolish AISB. Animals 96-07, 96-03, and 96-05 
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all stereotyped normally to apomorphine proving that the post- 
synaptic receptors were intact. 96-05 showed a particularly intense 
gnawing behavior to apomorphine, perhaps due to a denervation 
hypersensitivity of the striatal DA receptors. 96-07, the only 
animal in this series with significant limbic flourescence 
depletion again demonstrated the previously described periodic 
staring behavior to amphetamine. 
It is of note that those animals with significant striatal 
DA depletion and subsequent loss of stereotypy to d-amphetamine 
ambulated around their cage throughout the time of amphetamine 
effect. Though no quantitation of the locomotion was made, it 
was clearly evident that these animals continued to show a 
locomotor response to the drug when normal animals were stereo¬ 
typing. Furthermore, it is of note that these animals con¬ 
tinued to show marked sniffing activity. 
It should be noted that in tubercle lesioned animals there 
was always some degree of loss of cortical NE terminals. This was 
due to the involvement of the median forebrain bundle which 
traverses the limbic dopamine areas dividing accumbens from 
tubercle. In most cases this involvement was minimal however. 
The nuc. striatermi nal i s dorsalis and ventralis were variously 
effected in some of the tubercle lesioned animals, especially 
when diffusion of 6-0HDA along the anterior commisure was evident. 
Involvement of these structures did not seem to correlated in 
any consistent manner however, with the behavioral changes des¬ 
cribed. This was also true for involvement of the nuc. septi 
medialis and lateralis. W>th caudate lesions it was possible to 

totally spare involvement of all limbic structures. The amygdala, 
being caudal to the caudalmost extent of brain sectioned was not 
examined. It is unlikely however that this structure would 
have been involved. 
Many of these animals lost weight after lesioning. Those 
animals that lost the most weight were the animals lesioned in 
the caudate. These animals were clearly adipsic and aphagic 
for about one week after lesioning and had to be tube fed to keep 
them through this period. They eventually began eating aga i n 
by about ten days but stayed at about 60% their initial prelesion 
weight. The caudate lesioned animals were also extremely placid 
and manageable showing a fair degree of catalepsy by not 
moving when placed on a tilted mesh surface. The tubercle 
lesioned animals were not noticeably different in their 
behavior from nonlesioned animals before drug testing. 
Some animals hadji n i t i a 1 1 y been lesioned in the midbrain. 
Figure 16 shows the histology after one such lesion ( electrolytic, 
8 mAmps x 60 sec. ). The area of involvement includes the 
ascending ML and NS tracts bilaterally. This animal fell to 
about 6C% of its prelesioned weight. When tested with d- 
amphetamine 5 mg/kg and pargyline 10 days after lesioning it 
failed to stereotype and showed the periodic staring behavior. 
This animal also showed intermittent autofe11 a tory activities to 
amphetamine plus pargyline, which were also noted in some animals 
with small electrolytic lesions of the tractus striohypotha1 amicus 
administered amphetamine plus pargyline. 
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Thus, it was possible by depleting striatal dopamine 
to abolish AISB, and the loss of AISB appeared dependent only on 
the volume of striatal DA dep1eted.Both antero-media 1 and 
antero-lateral lesions could decrease or block AISB ( compare 
figures 13 and /5~ ). Limbic DA does not appear to be 
necessary for this effect of amphetamine. Furthermore, it 
was demonstrated that the loss of stereotypy was due solely 
to the loss of striatal dopamine since apomorphine was still 
able to elicit stereotyped behavior in these animals. 

Discussion 
These experiments have demonstrated that it is the 
nigro-striatai dopamine tract that mediates amphetamine in¬ 
duced stereotyped behavior. Dopamine in the olfactory tubercle 
and nuc. accumbens does not appear to be in any way necessary 
for amphetamine to induce this behavior. These conclusions 
have been reached by lesioning the forebrain terminal areas 
of these two pathways with 6-OHDA. It was possible to 
completely abolish AISB by the depletion of DA from the striatum, 
without any involvement of the limbic areas. On the other 
hand, lesion of the nuc. accumbens and olfactory tubercle without 
striatal depletion of DA did not prevent AISB but did result 
in a periodic staring behavior upon drug testing. Furthermore, 
it was demonstrated that the striatal lesions prevented stereo¬ 
typy solely by the depletion of presynaptic DA stores, since 
the administration of apomorphine did produce the normal 
stereotyped response in these animals. 
Though never definitively proven, it has been thought 
that stereotypy to stimulant drugs was mediated by striatum 
ever since Amsler prevented apomorphine stereotypy by lesioning 
this area ( Amsler, 1923 ). Three recent papers, however, made 
it appear very 1ikely that AISB might have been mediated through 
the meso—1imbic pathway. Simpson and Iversen ( 1971 ) reported 
that bilateral lesions of the substantia nigra in rats did not 
alter AISB. The histology presented by these authors however 
makes it apparent that the entire extent of nigra was not 

lesioned. In the present experiments it was found that depletion 
of a considerable degree of the striatal DA bilaterally was 
necessary to abolish AISB. Thus, the negative finding might 
be attributable to incomplete lesions. These authors also 
used a scheme of quantitation of head movements for scoring of 
stereotypy. These experiments have shown that lateral head 
movements, which appear in grade 2 stereotypy, are not an 
adequate measure of stereotypy by themselves. Graduation 
to grade 3 and 4 stereotypies in the present experiments was 
determined by the onset of compulsive oral activities. Thus, 
the nigral lesioned animals reported by Simpson may in fact 
have exhibited a lower grade of stereotypy than controls that the 
authors were unable to see due to their scoring scheme. The 
second paper by Iversen on this subject ( Creese and Iversen, 
1972 ) reported the success of 6-OHDA lesions of the NS path¬ 
way to prevent AISB. The coordinates given by the authors 
for their cannula placement made it obvious however that 
they had lesioned both the NS and ML pathways. Since their 
only control for efficacy of lesion was the determination of 
striatal tyrosine hydroxylase content they did not in fact 
have any proof for the specificity of their lesion. The 
present experiments have justified the conclusion of AISB 
mediation by the NS system, which was unjustly inferred from 
the previous work. It is of note that in this second paper 
Iversen reported that the locomotor stimulant effect of the 
"nigral" lesioned animals, as determined by photocell 
counts/min. was lower in the second hour after injection of 

amphetamine than was the control group. This loss of locomotor 
stimulation is usually attributed in the second hr. post 
amphetamine to the onset of stereotypy. It is likely that 
the decrease in photocell counts/min. in the second hr. 
post amphetamine in Iversen's "nigral animals" was due to the 
appearance of the periodic, immobile staring behavior which 
would have resulted from the additional lesion of the 
mesolimbic DA pathways in these animals. These authors did 
note that the depletion of striatal dopamine did not prevent 
the locomotor stimulation to amphetamine, as was also observed 
in the present experiments. 
McKenzie ( 1972 ) reported that suctioning out the olfactory 
tubercle significantly decreased or abolished stereotypy to 
apomorphine. He postulated from this that limbic dopamine 
mediated the stereotyped response. He does note however that 
destruction of neural tissue other than dopaminergic may have 
been responsible for the inhibition of stereotyped behavior. 
The present experiments confirm this possibility. It may be 
noted that electrolytic lesions of extensive ( but not complete ) 
portions of NAc and NAc-*0T performed by this i nvest i gator, 
resulted in the modification of stereotyped response in some animal 
but did not prevent that stereotyped response to amphetamine. 
It is more problematic however^ to explain McKenzie's report 
in the same paper that lesions of the striatum did not signifi¬ 
cantly reduce stereotyped behavior to apomorphine. The present 
experiments and all other previous reports on the relation of 
striatum to stereotypy have shown that striatal lesions reduce 

stereotypy to drugs ( Amsler, 1923; Fuxe and Ungerstedt, 1970; 
Anden, 1970; Naylor and Olley, 1972 ). 
Thus, the present experiments confirm the hypothesis that 
AISB is in fact mediated through the nigro-striata1 system. 
The loss of stereotypy seems to parallel the extent of striatal 
depletion. Fuxe ( Fuxe and Ungerstedt, 1970 ) reported that 
small electrolytic lesions in the dorsal anterior striatum 
seemed capable of preventing the biting aspect of AISB, and 
suggested from this that a topographic organization of stereotyped 
responses might exist in the striatum. The present experiments 
show the loss of stereotypy to be proportional to the extent 
of anterior caudate depleted, apparantly independent of the 
specific area involved. As long as 50% of the anterior caudate 
is depleted of dopamine, be it the vento-1atera1 1/2 or the 
dorsomedial 1/2, the animal will not stereotype. The graded 
responses of animals to lower doses of both amphetamine and 
apomorphine also tend to link degree of stereotypy to the degree 
of striatal DA stimulation. 
The findings reported here of decreased body weight after 
6—0HDA lesions agree with Ungerstedt ( 1971 ), who has im¬ 
plicated interruption of the NS pathway in the MFB as the 
crucial factor in lateral hypothalamic lesions to account for 
the classic behavioral findings of adipsia and aphagia. Those 
animals in the present experiments that showed the most marked 
adipsia and aphagia, requiring tube feeding for a week after 
the lesion, were the animals lesioned in the striatum. 
The caudate has classically been conceived of as a 

structure involved in the control of movement. The well known 
links of motor cortex-caudate-globus pallidus - VA and VL nuc. of 
the thalamus - motor cortex, and the many motor disturbances 
resulting from striatal pathology have all strengthened this 
concept. Recent physiologic and behavioral studies have sug¬ 
gested however, that the caudate may also be involved in the 
regulation of complex behavioral activities ( for review of 
this literature see Cools, 1973 and Brodal, 19&9 )• Kemp 
and Powell ( 1971 ) have concluded from detailed light and 
electron microscopic examination of the synaptic organization 
of the caudate that this structure must elaborate a highly 
integrated and modified version of the messages received 
by it from cortex. It is of note that a 11 cortical areas 
project to caudate ( Kemp and Powell, 1970 )• While there is 
somatotopic organization of input, any one area of striatum 
will be played upon by two cortical regions and receive 
numerous input from adjoining areas of striatum. Furthermore, 
it is of note that the medial portions of the head of the 
caudate are projected to by orbital frontal cortex, insula and 
opercula and in return project to the internal segment of the 
globus pallidus which projects to the intralaminar thalamic 
nuclei ( esp. CM ) and ventral midbrain tegmentum as well as 
to the VL nuc. of the thalamus. Thus, this medial portion of 
caudate becomes a link betwen limbic and motor systems. Kemp 
and Powell note ( 1970 ) 

If this correlation is correct, it is tempting 
to speculate that its significance lies in the re¬ 
cent evidence for a final convergence of the three 
major sensory pathways, through association 
cortical connections, in the depths of the superior 
temporal sulcus, at the frontal pole and in the 
cortex of the frontal operculum, and that all 
these regions are interconnected with each other 
and with the cortex on the orbital surface of the 
frontal lobe and with the temporal pole. It is 
possible, therefore, that through these regions 
of cortex the medial parts of the striatum and 
the internal segment of the globus pallidus are 
receiving an influence which represents a complex 
integrating not only of all the sensory pathways 
but also of the areas of "association" cortex 
of the frontal and parietotemporal lobes. 
Such a juncture of sensory, associative and motor information 
processing in the medial striatum would be a most attractive 
place for a lesion to account for schizophrenia. Perhaps it 
is an alterat ion of dopamine in the medial striatum that 
lies at the basis of this disorder. Thus, the stereotypies 
of thought so characteristic of this disorder may result from 
an aberrant processing of associative cortical material in 
the medial striatum just as the motor stereotypies result 
from an aberrant processing of motor impulses. Both Klawans 
( 1972 ) and Cools ( 1973 ) have suggested the striatum as 
the site of pathogenisis for schizophrenic psychosis. 
One of the major factors mitigating against the striatum 
as seat of pathogen sis in psychosis would seem to be that of 
the effect of anticholinergic medications. As previously dis¬ 
cussed, while such medications successfully alleviate the 
extrapyramidal side effects of the neuroleptics they do not 
seem to block the antipsychotic effects of these drugs. 

In this regard it is interesting to reexamine clozapine. As 
previously mentioned, this drug demonstrates good antipsychotic 
potency but does not produce extrapyramida 1 side effects. It 
also does not block apomorphine induced stereotypy. Further¬ 
more, it increases the turnover of DA in the limbic areas to 
a greater extent than it does in the striatum. It was hypothe¬ 
sized that clozapine might represent a case of DA receptor 
specificity differentiating between NS and ML systems. Another 
possibility however is that the anticholinergic effects of 
clozapine tend to autoa11eviate any of the extrapyramida 1 
symptons it might induce, and tend to potentiate the stereotypy 
that the drug would attempt to block. If this were the case, 
then receptor differentiation between ML and NS systems need 
not be invoked. Snyder ( unpublished ) has recently offered 
evidence along these lines, showing that clozapine had the 
greatest anticho1inergic potency of the neuroleptics tested 
in his lab, and, furthermore, that the ability of these 
medications to induce extrapyramida 1 effects seemed to be in¬ 
versely proportional to their anticholinergic potency. 
Thus, alteration of cholinergic tone can effect stereotyped 
behavior and extrapyramida 1 motor symptoms, both shown to be 
striatal phenomena, but apparently not psychosis. Perhaps then 
psychosis is mediated through the mesolimbic pathway. 
The incidence of psychosis in Parkinsonian patients treated 
with L-Dopa is greatest in that segment of the population with 
organic brain syndromes, and this psychosis is accompanied 70% 

of the time by oral dyskinesias ( Celesia and Barr, 1970 ). 
Iversen ( 1971 ) has reported that lesions of frontal cortex 
potentiate stereotypy in the rat. It may be hypothesized that 
frontal cortex exerts some sort of inhibitory influence on DA 
mediated activity in the striatum. Fuxe and Ungerstedt ( 1970 ) 
have reported that transactions separating frontal pole and 
olfactory bulb from the rest of the brain, very similar to 
the transection used clinically for frontal leucotomies, 
were capable of potentiatincp the behavioral effects of 
amphetamine in rats. In these rats, clonidine administration was 
capable of eliciting behavioral activation, exploratory 
activity and biting, which resulted in unlesioned animals only 
after the administration of apomorphine along with clonidine. 
It has also been reported that the incidence of tardive 
dyskinesias is extremely high in frontal leucotomized 
patients receiving neuroleptics. The neuroanatomic link of 
frontal motor cortex with striatum is classically known. The 
link of associative, orbital frontal cortex with medial striatum 
has been discussed. It should also be noted that frontal orbital 
cortex is probably linked to olfactory tubercle also. Thus, 
those patients with organic brain syndromes who manifest 
evidence of frontal lobe disease seem to show an increased 
sensitivity to both the motor and psychic effects of L-Dopa 
therapy. It might also be wondered to what extent the frontal 
degeneration in patients with Huntington's chorea adds to their 
hypersensistivity to striatal DA. It would be of considerable 

interest to know the mechanism of this frontal cortical 
influence on dopamine activity. It does not appear to be 
the result of direct alteration of dopamine levels ( Iversen, 
1971 )• Is it mediated through acetylcholine? GABA? If 
psychosis were mediated by the ML pathway and motor phenomena 
by the NS it might be of interest to know if tumors or gun¬ 
shot wounds etc. of non-orbital frontal cortex, since no 
projection from this area to tubercle and accubens is known, 
would result in an increased sensitivity to L-Dopa induced 
dyskinesias without accompanying psychosis. 
Thus, though it has been established that AISB is mediated 
by striatal dopamine, it is still not at all clear whether 
AISB is in fact a valid animal model for psychosis. 
The initial drug studies reported here resulted- in several 
interesting findings. The threshold doses for stereotypy to 
the d and 1 isomers were considerably greater than those pre¬ 
viously repoted by Snyder ( Taylor and Snyder 1970 ). ( 5-0- 
7-5 mg/kg for d and approx. 25 mg/kg for 1 as opposed to 
Snyder's report of 2.1 for d and 4.4 for 1 ) Part of this 
difference is accounted for by Snyder's pretreatment of his 
animals with an MAO inhibitor, but even with pargyline pre¬ 
treatment in these studies the threshold response to 1 
amphetamine was greater than 10 mg/kg. ( It is interesting to 
note that in a recent report by Lai and Sourkes ( 1973 ) the 
ED50 for stereotypy to d-amphetamine was determined to be 2.8 
mg/kg. These investigators compared their result very favorably 

to that of the 2.1 mg/kg reported by Snyder. Snyder however 
pretreated his animals with an MAO inhibitor, Lai and Sourkes did 
not. It is thus very likely that two different criteria for 
stereotypy were used ). More importantly however, the ratio 
of effective dose was found to be 3-^:1 ( 1:d ) to elicit AISB. 
This was clearly greater than the 2:1 reported by Snyder. The 
present finding agrees very nice1y,however, with the report 
of VonVoigt1ander and Moore ( 1973 ) of a 3-^ x greater 
potency of the d isomer than the 1 to stimulate release of 
DA in vivo in the rat. The present result also tends to agree 
more with Bunney and Aghajanian ( 1973 ) who find that the d 
isomer is 6-10 times more powerful than the 1 in producing a 
50% inhibition of spontaneous firing rate of DA neurons. This 
data all mitigates against the proposed equipotency of d and 1 
amphetamine on DA neurons as inferred by Snyder from his data. 
In this regard the report by Angrist ( 1972 ) of the equipot¬ 
ency of the d and 1 isomers of amphetamine in eliciting 
amphetamine psychosis becomes problematic to a DA theory of 
psychosis. This was a very small study however, and needs to 
be repeated. Such a finding may indicate a role for NE in 
the induction of psychosis. In this regard it should be 
noted that the antipsychotic neuro1eptics,in addition to their 
DA receptor blockade and anticholinergic properties, also possess 
©(-adrenergic blocking abilities. The significance of this action 
for their clinical effectiveness is unknown. 
It has been suggested ( Fuxe and Ungerstedt, 1970 ) 

that the particular type of behavior elicited by amphetamine, 
locomotor stimulation or stereotypy, is dependent upon the 
relative activities of the NE and DA systems. If NE activity 
is dominant one sees locomotor activation, if DA prevails 
then stereotypy emerges. Since amphetamine is more potent 
on NE release than DA release ( Azzuro and Rudledge, 1973 
the lower threshold for LS than SB agrees with this hypothesis. 
The finding of a speedier onset and stronger degree of stereotypy 
to d-amphetamine after pretreatment with phenoxybenzamine also 
supports this hypothesis. The results of treatment with 
phenoxybenzamine and clonidine further indicate that while 
NE many not be necessary for the induction of A1SB, alteration 
of NE tone can alter the nature of the stereotypy observed, 
though not in any simple manner. 
In early time periods after d-amphetamine when NE pre¬ 
dominance may be expected, the behavior observed is LS. If NE 
is blocked, then SB becomes manifest earlier. If additional 
NE stimulation is added to an animal who already has a high 
level of DA activity however, the increased NE increases the 
intensity of the SB. Thus, clonidine led to intense gnawing 
when administered to d-amphetamine treated animals. But for a 
period of approximately 30-40 min., those animals given clonidine 
30 min. after amphetamine also displayed extreme LS behavior 
( violent jumps ) intermittently with their gnawing. At these 
high levels of stimulation of both DA and NE systems, the 

alternation between LSI and SBi may result from small momentary 
imbalances of activity of the 2 amine systems. The animals 
administered clonidine prior to amphetamine did not show a 
delay in onset of SB. Thus, it might be that levels of SB are 
dependent on the attainment of certain absolute levels of DA 
stimulation. While decreasing the NE tone may hasten the onset 
of SB, once the requisite DA activity has been achieved, in¬ 
creasing NE will only intensify the SB. 
It must also be noted that doses of amphetamine sufficient 
to induce stereotypy ( greater than 5mg/kg ) are capable of 
stimulating release of the ext ragranu1 ar store of 5“HT ( Fuxe 
and Ungerstedt, 1970). Though the role of 5“HT in AISB is not 
clear, as previously discussed, there does seem to be a 5~HT 
inhibitory influence on the locomotor stimulation of amphetamine 
( Mabry and Campbell, 1973)- The autofellatory behavior seen with 
d-amphetamine and pargyline treatment of rats lesioned in the 
ventral tegmentum ( involving the ascending DA pathways) or 
in the tractus striohypotha1 amicus ( of the substantia innom- 
inata, whose relation to " ventral striatum " has been discussed) 
may involve an abberant interaction of DA and 5-HT systems 
resulting from the lesions. This abnormal sexual activity was 
not seen in rats that received amphetamine without pargyline. 
5-HT has been noted to play a role in the control of sexual 
activity. Angrist ( personal comm. ) has noted that pretreat¬ 
ment of dogs with parach1oropheny1 a 1 anine prevents the increased 
sexual activity normally seen after amphetamine administration. 
. 
Thus, it is probable that the activities of all the mono- 
amine systems as well as that of the cholinergic system will 
all combine to effect the stereotypy observed. In investigating 
the effect of any particular drug on AISB it would thus be desir¬ 
able to know its actions on all of these systems and not merely 
on the DA system alone. 
Grade 1 stereotypy, which consisted of sniffing the air 
with occaisional head movements, was seen in many animals 
prior to the onset of h igher— 1 evels of stereotypy and was 
especially prominent in those rats administered low doses of 
1-amphetamine. Azzaro and Rutledge ( 1973 ) have demonstrated 
that d-amphetamine shows a decreasing potency of release of 
amines from brain slices in the order NE>DA>5~HT with NE 
being the amine released at lowest concentrations of amphet¬ 
amine and 5~HT release requiring the highest concentration. 
Bunney ( pers. comm.) has found that the 1 isomer of amphetamine 
is more potent in inhibiting the firing of cells in the locus coer- 
uleus ( an NE cell group ) than in the A9 cell group, suggesting 
the 1 isomer to be a potent NE releaser ( unlike Snyder's 
earlier report of a low potency of the 1 isomer on the NE 
system). Thus, with low doses of 1-amphetamine, which tend to 
stimulate the NE system more than the DA, and in the early 
stages of the drug effect with d-amphetamine, when the low drug 
levels would probably result in a greater NE than DA effect, we 
find the animal's head up sniffing the air. ( This grade of 
stereotypy was also observed in rats 1 mg/kg of apomorphine. 
However, since the behavior after apomorphine is almost immediate 
in onset and of very short duration with low doses, it would not 
be unexpected for the animal to have an increased NE tone during 

this period due to the excitement of the injection). 
Amphetamine is known to alter postural reflexes. With increasing 
degrees of DA activity in later time periods after d-amphetamine 
the animal progresses from this predominant extensor state to 
a predominant flexor state, exhibiting the typical hunched 
posture. Since sniffing was seen even in the caudate lesioned 
animals that did not stereotype at all to amphetamine, it must 
be concluded that the sniffing induced by amphetamine is not 
mediated by the same striatad- DA system that mediates SB, or 
perhaps not by striatal DA at all. Sniffing would not then 
seem to be a part of the stereotyped behavior induced by amphet¬ 
amine, but rather a result of the generalized activation produced 
by the drug, probably mediated predominantly by NE. 
Anden ( Anden et al., 1973 ) and Svensson (1971) have offered 
considerable evidence to indicate that DA receptor stimulation 
as well as NE stimulation is necessary for the locomotor activ¬ 
ation produced by amphetamine. It was noted in these experiments 
that in animals administered low doses of 1-amphetamine^loco¬ 
motor stimulation did not appear as marked as that seen with 
d-amphetamine. This may have resulted from the predominant NE 
stimulation without DA stimulation that may have resulted from 
the low doses of the 1 isomer. If correct, such an explanation 
would agree with the necessity for DA stimulation in LS. 
The observation of decreased LS was only casual however. 
Formal testing of the LS response to 1-amphetamine would seem 
worthwhile. The ability of d-amphetamine or apomorphine + 

c 1 on i d i ne to incr ea s e rno t i 1 i t y 3 n d r gs ctivity of reserpine 
pretreated striatomized rats led Anden(l970) to postulate a 
role for DA receptors outside the striatum in the regulation 
of activity and alertness. Naylor and 01 ley(1972) have also 
reported that striatal lesions which did block stereotypy to 
amphetamine did not alter the locomotor response. The animals 
here/in which striatal dopamine was depleted, and who did not 
show AISB, did show a prolonged motor stimulation. Thus, these 
experiments agree with Anden and suggest further that limbic 
DA may be involved in the locomotor activation produced by 
amphetamine. 
A peculiar periodic staring behavior was observed in animals 
administered low doses of 1-amphetamine after MAO inhibition. 
It was of considerable surprise to once again see this behavior 
exhibited by animals depleted of limbic DA when they were tested 
with d-amphetamine. This behavior was seen in animals given 
d-amphetamine only if limbic DA was depleted. It is possible 
that the staring episodes seen with low doses of 1-amphetamine + 
pargyline and in ML lesioned animals administered d-amphetamine 
may result from a predominant NE stimulation without the requisite 
limbic DA activation to allow for a normal active response. 
( For further discussion of this behavior and its possible sig¬ 
nificance refer to Appendix). 
It has thus been demonstrated that loss of DA from OT and 
NAc does not prevent AISB, but does seem to alter the locomotor 
response to amphetamine. Observations of LS in this study were 
not however quantified. Such quantification of LS by use of 
an Annimex activity meter in NS and ML 6-OHDA lesioned animals 

might serve to more precisely define the role of one or the other 
of the DA systems in LS induced by amphetamine. 
It has been demonstrated that 6-OHDA induced lesions of 
anterior caudate do block AISB. This effect is due solely to 
the loss of striatal DA, since apomorphine can still induce 
normal stereotypies in these animals. The present study has 
limited the area of lesion to anterior caudate, rostral to 
A 7190. It would be of interest know if lesions of more caudal 
caudate are also effective in. blocking AISB. While the present 
study has tended to indicate that the reduction of stereotypy is 
proportional to the amount of striatum depleted of DA, a somat- 
otopic organization of stereotyped responses has not been 
ruled out. The present method of subjective approximation of 
of decreased flourescent intensity as a measure of DA depletion 
might be extended by spectrof1ourophotometric analysis to yield 
more reliable quantitation of DA loss. 
V/hile it has been established that AISB is mediated by the 
nigro-striata1 DA pathway, the validity of AISB as an animal 
model of psychosis is still uncertain. 

Append ix 
Periodic Staring Behavior - 
possible relation to Catatonia 
Naylor and 011ey(1972) reported that concurrent with the dec¬ 
reased AISB resulting from lesions of the caudate was the 
appearance of a 11 periodic cataleptic behavior." Their first 
two grades of this behavior describe the animals as " alert 
appearance but no motor activity. Indifferent to observer and 
brief response to touch, inability to correct suspended pos~ 
ition." This description sounds remarkably close to that of the 
periodic staring behavior described in these experiments. Naylor 
and 01 ley commented 
The finding of a cataleptic type behavior in animals with 
bilateral lesions of the caudate nucleus, caudate-putamen 
and globus pallidus after administration of amphetamine 
was surprising... no previous reference could be found 
suggesting any cataleptic abi1ity( of amphetamine). A 
present understanding of the proposed mechanism of action 
of amphetamine does not suggest an explanation. 
Since an apparantly identical behavior could be elicited 
to d-amphetamine in rats depleted of limbic DA, two possible 
explanations for Naylor and Oiley1s findings present themselves. 
First, the lesions may not have been specific for striatum and may 
have encroached upon 0T and NAc. Unless this were specifically 
looked for it might easily be missed, especially if one's attent¬ 
ion were directed to avoiding involvement of the internal cap¬ 
sule as was Naylor and Olley's. A second possibility is that the 
neural processing to effect the motor responses mediated by limbic 
DA involves the striatum. Hence, the gross destruction of striatal 
tissue might mimic the effect of specific limbic DA depletion. 

( This once again points out the difficulty of drawing conclusions 
about the role of "striatal DA" as a result of altered behavioral 
response after lesions producing generalized striatal necrosis or loss) 
Wilson(l972) in his examination of the neuroanatomy of the NAC 
quotes at length a description of behavior elicited in cats by stimulat 
ion of the accumbens. 
The second response consistently obtained was evoked by prolonged 
stimulation of the floor of the remaining portion of the frontal 
horn of the ventrical, between the head of the of the caudate 
and the septum, at or just in front of the anterior commisure. 
After a latent period of 1 to 5 sec, the pupils dilated moderate¬ 
ly, following which respirations became much more rapid, the 
depth and rate increasing with the duration of stimulus. The 
animal showed no other signs which could be interpreted as pain, 
fear, or rage, but sat or stood rather tensely. When the stimulus 
had continued for 5 to 10 sec, there was a sudden burst of activ¬ 
ity in the form of violent running and springing movements 
which continued for 1/2 min or more after the stimulation ceased 
and gradually subsided. At the end of the outburst the animal 
sat or stood on the table as quietly as before, the pulse and 
respirations rapidly returning to normal... 
( Rioch and Brenner,1938) 
Elicitation of behavior by stimulation of brain regions must always 
be critically examined to rule out spread of exciting current to 
to other areas. Nonetheless, the description °f tense, motionless 
cafewith dilated pupils is very similar to the staring behavior 
described in these experiments with rats. Furthermore, the violent 
springing of the cats is quite comparable to a peculiar behavior 
observed in some rats by Fuxe and Ungerstedt (1970)• 
After bilateral electrocoagulations of the neostriatum, without 
damage to other structures, interesting behavioral effects were 
observed following treatment with a high dose of amphetamine 
(5-10 mg/kg) or apomorphine(5 mg/kg) with clonidine(2 mg/kg). 
Marked hyperactivity with running around and stereotyped activ¬ 
ity were no longer observed. Instead, the rats were now immobil¬ 
ized most of the time but performed very fast intermittent 
jumps, which were jerky in character and ended rapidly. 
Fuxe and Ungerstedt concluded that " increased DA receptor activity 
in the limbic forebrain area may be of importance in this behavior." 

Evidence thus seems to be accumulating to involve limbic DA 
areas in the control of levels of motor activity. It is interesting 
to speculate on what the appearance might be in humans of disorders 
in this area. 
Catatonic symptoms... are psychomotor acts frequently seen in 
schizophrenic patients and by no means limited to the so-called 
catatonic type. The two most extreme symptoms are catatonic 
stupor and catatonic excitement. In stuporous states, patients 
are mute and immobile, they are negativistic and will neither eat 
nor drink; they do not take care of their body needs... They seem 
to be less bothered by fatigue than normal persons would be... 
Those stuporous patients that can be induced to give accounts 
of their experience speak about a strange dream-like state... 
The striking thing about stupor is that the musculature is 
dissociated very much the way a patient can be "taught" in 
hypnosis that his will and his actions can be separated... 
Catatonic excitemnt is a severe state of agitation with sudden 
onset and indiscriminate violence. 
( Redlich and Freedman,1966) 
... Even when the patient seems immobile and stuporous, he looks 
so tense and explosive that those around him feel apprehensive 
and uncomfortable - and not without reason for he may become 
excited and assaultive without obvious provocation. 
( Detre and Jarecki,197i) 
Indeed, it was only with the utmost reluctance that this in¬ 
vestigator determined the cataleptic nature of the periodic staring 
behavior, because the appearant tenseness of the rat made him think 
the animal would spring violently at the slightest touch. E1kes(1957) 
has reported that some catatonics administered methamphetamine appeared 
to sleep - a most bizarre and paradoxical response to this normally 
alerting drug. Furthermore, bulbocapnine has long been used to elicit 
a catatonic like state in animals ( Dejong, 19^+5) . The structur of 
bulbocapnine is remarkably similar to that of apomorphine. ( See 
figl7). Bulbocapnine has also been reported to block AISB in rats 
( Tseng and Walaszek,1972). 

it seems not unreasonable to suggest that a disorder of limbic 
dopamine may be involved in the pathogenesis of the peculiar disorders 
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